# Ischemic Hepatitis as the Presenting Manifestation of Cardiac Amyloidosis

**Authors:** Chelsey A. Petz, Thomas Todoran, Don C. Rockey

PMC · DOI: 10.1177/2324709614558064 · 2014-11-12

## TL;DR

This paper discusses how sudden liver enzyme elevation can be a sign of heart disease, specifically cardiac amyloidosis.

## Contribution

The paper highlights the importance of considering cardiac dysfunction as a cause of hypoxic hepatitis.

## Key findings

- Ischemic hepatitis can be a presenting sign of cardiac amyloidosis.
- Advanced imaging improves the diagnosis of infiltrative heart diseases like amyloidosis.

## Abstract

An abrupt elevation in aminotransferases without clear etiology may be attributed to hypoxic hepatitis. Underlying cardiac dysfunction, an important clinical clue, is often overlooked as a cause of hypoxic hepatitis, and understanding the interdependence of the heart and liver is crucial in making this diagnosis. Causes of cardiac dysfunction may include any of many different diagnoses; infiltrative heart disease is a rare cause of cardiac dysfunction, with amyloidosis being the most common among this category of pathologies. More advanced imaging techniques have improved the ability to diagnose infiltrative heart disease, thus allowing quicker diagnosis of conditions such as amyloidosis.

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** viral hepatitis (MESH:D014777), lower extremity edema (MESH:D004487), Vomiting (MESH:D014839), centrilobular necrosis (MESH:D011656), decreased cardiac output (MESH:D002303), cardiomyopathies (MESH:D009202), left ventricular hypertrophy (MESH:D017379), hepatic injury (MESH:D056486), hemochromatosis (MESH:D006432), dyspnea (MESH:D004417), hypoxic (MESH:D002534), hepatic necrosis (MESH:D047508), Amyloidosis (MESH:D000686), valvular abnormalities (MESH:D006349), Biliary tract disease (MESH:D001660), enzyme (MESH:D008661), arrhythmias (MESH:D001145), Ischemic Hepatitis (MESH:D000081011), gallstone (MESH:D042882), type 2 diabetes mellitus (MESH:D003924), shock (MESH:D012769), nausea (MESH:D009325), biventricular hypertrophy (MESH:D006984), hepatomegaly (MESH:D006529), orthostasis (MESH:D004244), heart failure (MESH:D006333), congestion of the liver (MESH:D017093), amyloid (MESH:C000718787), pain (MESH:D010146), Hepatitis A to C (MESH:D019698), sarcoidosis (MESH:D012507), atrioventricular block (MESH:D054537), ischemia (MESH:D007511), cardiac abnormalities (MESH:D018376), diastolic dysfunction (MESH:D018487), Infiltrative diseases of the heart (MESH:D006331), hyperlipidemia (MESH:D006949), right ventricular hypertrophy (MESH:D017380), hypertension (MESH:D006973), atrial fibrillation (MESH:D001281), cardiovascular dysfunction (MESH:D002318), skin lesions (MESH:D012871), biatrial enlargement (MESH:D006332), coronary disease (MESH:D003327), bradycardia (MESH:D001919), chronic kidney disease (MESH:D051436), left anterior fascicular block (MESH:D002037), myocardial disease (MESH:D004194), abdominal symptoms (MESH:D000007)
- **Chemicals:** furosemide (MESH:D005665), glipizide (MESH:D005913), metoprolol tartrate (MESH:D008790), gadolinium (MESH:D005682), potassium (MESH:D011188), simvastatin (MESH:D019821), creatinine (MESH:D003404), bicarbonate (MESH:D001639), acetaminophen (MESH:D000082), aspirin (MESH:D001241), oxygen (MESH:D010100), sodium (MESH:D012964), bilirubin (MESH:D001663)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4528876/full.md

---
Source: https://tomesphere.com/paper/PMC4528876